← Back to Issue

The Molecule Era Ended

From AI Secret · subscribed via aiste.ulozaite@gmail.com · original ↗ · unsubscribe

  • Merck and Moderna’s personalized mRNA cancer vaccine met trial goals, cutting melanoma recurrence in half and spread by 59%
  • AI analyzes tumor DNA to predict which mutations trigger immune response, then synthesizes corresponding mRNA
  • Pharmaceutical industry’s competitive advantage shifted from discovering molecules to training AI to read tumors

Moderna shares surge after it announces a positive cancer trial result AP News

AP Logo

Menu

MORE

Sign in

Search Query Submit Search

Show Search Menu

Submit Search

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

AP Logo

Menu

MORE

Sign in

Search Query Submit Search

Show Search Menu

Submit Search

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Business

Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test

        ![A sign marks an entrance to a Moderna building in Cambridge, Mass., May 18, 2020. (AP Photo/Bill Sikes, File)prnto](https://dims.apnews.com/dims4/default/0119d68/2147483647/strip/true/crop/3839x2559+0+0/resize/320x213!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F27%2F46%2Fecc71d1055b7d69c32c17c0079ea%2F6552e992b2e342cb89bd11d2672e531c)

A sign marks an entrance to a Moderna building in Cambridge, Mass., May 18, 2020. (AP Photo/Bill Sikes, File)prnto

By  THE ASSOCIATED PRESS

Leer en español 

Add AP News on Google Add AP News as your preferred source to see more of our stories on Google. Share

Comments

Share

  • [

    Facebook](https://www.facebook.com/dialog/share?app_id=870613919693099&display=popup&href=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3DFacebook%26utm_medium%3Dshare)

  • Copy

    Link copied

  • Print
  • [

    Email](/cdn-cgi/l/email-protection#a996cbc6cdd094e4c6cdccdbc7c88c9b99dac1c8dbccda8c9b99dadcdbcecc8c9b99c8cfddccdb8c9b99c0dd8c9b99dac8d0da8c9b99c0ddda8c9b99ccd1d9ccdbc0c4ccc7ddc8c58c9b99c4fbe7e88c9b99cac8c7caccdb8c9b99dddbccc8ddc4ccc7dd8c9b99d9c8dadacccd8c9b99c88c9b99c2ccd08c9b99ddccdadd8c99e88c99e8c1ddddd9da8c9ae88c9bef8c9befc8d9c7ccdeda87cac6c48c9befc8dbddc0cac5cc8c9befc4c6cdccdbc7c884c4dbc7c884c4ccdbcac284cac8c7caccdb84c4ccc5c8c7c6c4c884c0c7ddc0dac4ccdbc8c784c2ccd0dddbdccdc8849b9a9a99cdcacc9e9991cb99c8cf9b989ccb9f919c9e99cb9890cd999b9ccdcf8c9aefdcddc4f6dac6dcdbcacc8c9aedecc4c8c0c58c9b9fdcddc4f6c4cccdc0dcc48c9aeddac1c8dbcc8c99e88c99e8e4c6cdccdbc7c88c9b99dac1c8dbccda8c9b99c4c6dbcc8c9b99ddc1c8c78c9b99cdc6dccbc5cccd8c9b99c8cfddccdb8c9b99c8c7c7c6dcc7cac0c7ce8c9b99c0c7c0ddc0c8c58c9b99dbccdadcc5ddda8c9b99cfdbc6c48c9b99c88c9b99dadddccdd08c9b99c6cf8c9b99c8c78c9b99ccd1d9ccdbc0c4ccc7ddc8c58c9b99cac8c7caccdb8c9b99dddbccc8ddc4ccc7dd87)

  • [

    X](https://twitter.com/intent/tweet?url=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3Dtwitter%26utm_medium%3Dshare&text=Moderna%20shares%20surge%20after%20it%20says%20its%20experimental%20mRNA%20cancer%20treatment%20passed%20a%20key%20test)

  • [

    LinkedIn](#)

  • [

    Bluesky](https://bsky.app/intent/compose?text=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3Dbluesky%26utm_medium%3Dshare%26nbsp%3B%3Cbr%3EModerna%20shares%20surge%20after%20it%20says%20its%20experimental%20mRNA%20cancer%20treatment%20passed%20a%20key%20test)

  • [

    Flipboard](https://share.flipboard.com/bookmarklet/popout?v=2&title=Moderna%20shares%20surge%20after%20it%20says%20its%20experimental%20mRNA%20cancer%20treatment%20passed%20a%20key%20test&url=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3DFlipboard%20Share%26utm_medium%3Dshare)

  • [

    Pinterest](https://pinterest.com/pin/create/bookmarklet/?url=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3DPinterest%26utm_medium%3Dshare&description=Moderna%20shares%20surge%20after%20it%20says%20its%20experimental%20mRNA%20cancer%20treatment%20passed%20a%20key%20test&media=https://assets.apnews.com/27/46/ecc71d1055b7d69c32c17c0079ea/6552e992b2e342cb89bd11d2672e531c)

  • [

    Reddit](https://www.reddit.com/submit?url=https%3A%2F%2Fapnews.com%2Farticle%2Fmoderna-mrna-merck-cancer-melanoma-intismeran-keytruda-2330dce708b0af215b68570b19d025df%3Futm_source%3Dreddit%26utm_medium%3Dshare&title=Reddit Share)

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators.

Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. In current studies, they are pairing it with Keytruda, a immunotherapy drug made by Merck.

The study compared using intismeran and Keytruda together on melanoma patients against using Keytruda alone. The companies said patients who received the combination lived longer without cancer returning or metastasizing than patients who got Keytruda alone.

The companies did not say how long patients survived without cancer returning or whether patients lived longer overall. They said they plan to present the study results at an upcoming international medical meeting.

Moderna shares rose more than 120% to $140.12 a share. Merck shares rose about 11%.

Most read

  1. Court cuts $50M judgment against Alex Jones over falsely labeling Sandy Hook killings a hoax

    4 MIN READ

    389

  2. Pentagon dismisses Stars and Stripes leadership after editor, reporter oppose military interference

    4 MIN READ

    428

  3. Supreme Court’s chief justice allows work on Trump’s $400M White House ballroom to continue for now

    3 MIN READ

    548

  4. live

    Trump in South Carolina to stump for Sen. Darline Graham ahead of GOP Senate runoff

  5. Trump announces plan to lower beef prices, but ranchers and some Republicans are already balking

    3 MIN READ

    347

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Copyright 2026 The Associated Press. All Rights Reserved.

  • [

    twitter](https://twitter.com/AP)

  • [

    instagram](https://www.instagram.com/apnews/)

  • [

    facebook](https://www.facebook.com/APNews)

Highlights & notes

    Notes